1. Drug Safety Update. Volume 11, Issue 12. 2018.
https://www.gov.uk/drug-safety-update/parenteral-amphotericin-b-reminder-of-risk-of-potentially-fatal-adverse-reaction-if-formulations-confused
.
2. National Patient Safety Agency. Rapid Response Report. Risk of confusion between lipid and non-lipid formulations of injectable amphotericin. 2007.
https://www.sps.nhs.uk/articles/npsa-alert-non-lipid-and-lipid-formulations-of-injectable-amphotericin-2007/
.
3. Institute for Safe Medication Practices (ISMP) Medication error prevention “Toolbox”. 1999.
https://www.ismp.org/resources/medication-error-prevention-toolbox
.
4. British National Formulary 76. Amphotericin.
https://bnf.nice.org.uk.
. Accessed 28th Oct 2019.
5. Mohr J, Hall A, Ericsson C, Ostrosky-Zeichner L. Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation. Pharmacotherapy. 2005;25(3):426–8.